Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
80,97 USD | +0,47 % | +4,13 % | +10,19 % |
Kurzporträt
Mitarbeiterzahl: 9 707
Umsatz nach Geschäftsbereich
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Bruker Scientific Instruments Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection
32,4
%
| 822 | 32,5 % | 960 | 32,4 % | +16,81 % |
Bruker Scientific Instruments NANO
31,8
%
| 787 | 31,1 % | 942 | 31,8 % | +19,68 % |
Bruker Scientific Instruments BioSpin
26,9
%
| 697 | 27,5 % | 799 | 26,9 % | +14,61 % |
Bruker Energy & Supercon Technologies
9,5
%
| 237 | 9,4 % | 281 | 9,5 % | +18,39 % |
Eliminations
-0,6
%
| -12 | -0,5 % | -17 | -0,6 % | +38,21 % |
Umsatz je Region
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
United States
26,2
%
| 696 | 27,5 % | 778 | 26,2 % | +11,72 % |
Rest of Europe
23,6
%
| 592 | 23,4 % | 700 | 23,6 % | +18,21 % |
China
17,8
%
| 397 | 15,7 % | 528 | 17,8 % | +33,19 % |
Rest of Asia Pacific
15,5
%
| 408 | 16,1 % | 461 | 15,5 % | +12,86 % |
Germany
9,5
%
| 247 | 9,8 % | 282 | 9,5 % | +13,78 % |
Other
7,3
%
| 190 | 7,5 % | 217 | 7,3 % | +13,76 % |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Frank Laukien
CEO | Chief Executive Officer | 64 | 01.02.91 |
Gerald Herman
DFI | Director of Finance/CFO | 66 | 01.12.16 |
Thorsten Thiel
IRO | Public Communications Contact | - | 01.10.10 |
Justin Ward
IRC | Investor Relations Contact | - | 01.01.22 |
Joseph Alldredge
LAW | General Counsel | - | 16.01.22 |
Falko Busse
PRN | Corporate Officer/Principal | 56 | 01.05.18 |
Jürgen Srega
PRN | Corporate Officer/Principal | 69 | 01.01.13 |
Mark Munch
PRN | Corporate Officer/Principal | 62 | 01.07.15 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
John Ornell
BRD | Director/Board Member | 66 | 19.08.15 |
William Linton
BRD | Director/Board Member | 77 | 01.02.00 |
Robert Rosenthal
BRD | Director/Board Member | 67 | 11.11.15 |
Frank Laukien
CEO | Chief Executive Officer | 64 | 01.02.91 |
Richard Packer
BRD | Director/Board Member | 66 | 01.05.07 |
Adelene Perkins
BRD | Director/Board Member | 54 | 01.01.17 |
Hermann Requardt
BRD | Director/Board Member | 69 | 06.08.15 |
Bonnie Anderson
BRD | Director/Board Member | 66 | 03.09.20 |
Cynthia Friend
BRD | Director/Board Member | 69 | 20.05.16 |
Philip Ma
BRD | Director/Board Member | 59 | 01.04.22 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 176 113 570 | 97 121 698 ( 55,15 %) | 30 778 879 ( 17,48 %) | 55,15 % |
Unternehmenskontakt
Konzerngesellschaften
Name | Kategorie und Branche |
---|---|
Bruker (Malaysia) Sdn. Bhd.
| |
RI Research Instruments GmbH
RI Research Instruments GmbH Telecommunications EquipmentElectronic Technology RI Research Instruments GmbH develops, designs, manufactures, and tests high performance components and systems. Its products include particle accelerators, XUV/EUV solutions, special manufacturing, pulsed power systems, fusion equipment, and beamline instrumentation. It serves the science, and medical and pharma industries. The company was founded in 2009 and is headquartered in Bergisch Gladbach, Germany. |
Telecommunications Equipment
|
Bruker Finance BV
Bruker Finance BV Finance/Rental/LeasingFinance Part of Bruker Corp., Bruker Finance BV is a Dutch company that provides financial services. The private company is based in Rotterdam, Netherlands. |
Finance/Rental/Leasing
|
Bruker India Scientific Pvt Ltd.
Bruker India Scientific Pvt Ltd. Medical SpecialtiesHealth Technology Part of Bruker Corp., Bruker India Scientific Pvt Ltd. is a manufacturer of high-performance scientific instruments and analytical solutions that support the research community in academia and industry. The private company is based in Mumbai, India. Bruker Corp. is headquartered in Massachusetts and manufactures scientific equipment for molecular and material research, industrial and application analysis. The Indian company's services provide customers with personalized support to ensure their instruments maintain maximized uptime and optimized productivity. |
Medical Specialties
|
Bruker EAS GmbH
Bruker EAS GmbH Medical SpecialtiesHealth Technology Bruker EAS GmbH engages in the development of novel superconductors based on powder metallurgy. The company was founded October 2, 2004 and is headquartered in Hanau, Germany. |
Medical Specialties
|
Sektor
Umsatz nach Geschäftsbereich
Umsatz je Region
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
+10,19 % | 11,77 Mrd. | |
+8,07 % | 219 Mrd. | |
+6,59 % | 183 Mrd. | |
+11,26 % | 133 Mrd. | |
+26,57 % | 108 Mrd. | |
+0,65 % | 63,06 Mrd. | |
+13,35 % | 52,02 Mrd. | |
-0,62 % | 48,2 Mrd. | |
-0,93 % | 40,37 Mrd. | |
+11,54 % | 39,35 Mrd. |
- Börse
- Aktien
- 813534 Aktie
- Unternehmen Bruker Corporation